{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T05:36:04Z","timestamp":1784007364651,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ijcard.2018.09.091","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T21:53:36Z","timestamp":1538430816000},"page":"54-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Insulin like growth factor binding protein 2 (IGFBP-2) for risk prediction in patients with severe aortic stenosis undergoing Transcatheter Aortic Valve Implantation (TAVI)"],"prefix":"10.1016","volume":"277","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2521-5609","authenticated-orcid":false,"given":"Johanna Maria","family":"Muessig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lichtenauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4024-0220","authenticated-orcid":false,"given":"Bernhard","family":"Wernly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Kelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Franz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"B\u00e4z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Christian","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Racher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Reiner","family":"Figulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Paar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta C.","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Rouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Lauten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2018.09.091_bb0005","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ahj.2014.07.017","article-title":"Transcatheter aortic valve replacement: historical perspectives, current evidence, and future directions","volume":"168","author":"Horne","year":"2014","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2018.09.091_bb0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4137\/CMC.S19217","article-title":"Transcatheter aortic valve implantation (TAVI): is it time for this intervention to be applied in a lower risk population?","volume":"8","author":"Panayiotides","year":"2014","journal-title":"Clin. Med. Insights Cardiol."},{"key":"10.1016\/j.ijcard.2018.09.091_bb0015","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.09.091_bb0020","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jacc.2012.01.001","article-title":"2012 ACCF\/AATS\/SCAI\/STS expert consensus document on transcatheter aortic valve replacement","volume":"59","author":"Holmes","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.09.091_bb0025","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.ijcard.2012.11.116","article-title":"Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation","volume":"168","author":"Lopez-Otero","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.09.091_bb0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3803\/EnM.2017.32.1.11","article-title":"Recent insights into insulin-like growth factor binding protein 2 transcriptional regulation","volume":"32","author":"Shin","year":"2017","journal-title":"Endocrinol. Metab. (Seoul)."},{"key":"10.1016\/j.ijcard.2018.09.091_bb0035","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1210\/er.2001-0033","article-title":"Cellular actions of the insulin-like growth factor binding proteins","volume":"23","author":"Firth","year":"2002","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ijcard.2018.09.091_bb0040","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2337\/db06-0436","article-title":"IGF-binding protein-2 protects against the development of obesity and insulin resistance","volume":"56","author":"Wheatcroft","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.ijcard.2018.09.091_bb0045","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/(SICI)1520-7560(199909\/10)15:5<314::AID-DMRR56>3.0.CO;2-E","article-title":"Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes","volume":"15","author":"Frystyk","year":"1999","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.ijcard.2018.09.091_bb0050","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/14017431.2014.891760","article-title":"IGF-I and IGFBP2 in peripheral artery disease: results of a prospective study","volume":"48","author":"Urbonaviciene","year":"2014","journal-title":"Scand. Cardiovasc. J."},{"key":"10.1016\/j.ijcard.2018.09.091_bb0055","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.cjca.2015.04.024","article-title":"Relationship between insulin-like growth factor binding protein-2 and left ventricular stroke volume in patients with aortic stenosis","volume":"31","author":"Carter","year":"2015","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.09.091_bb0060","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/gm517","article-title":"Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases","volume":"5","author":"Prentice","year":"2013","journal-title":"Genome Med."},{"key":"10.1016\/j.ijcard.2018.09.091_bb0065","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/eurheartj\/ehn523","article-title":"Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement","volume":"30","author":"Osswald","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.09.091_bb0070","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jacc.2009.12.014","article-title":"Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience","volume":"55","author":"Rodes-Cabau","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.09.091_bb0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/icvts\/ivs098","article-title":"Late gadolinium enhancement as a potential marker of increased perioperative risk in aortic valve replacement","volume":"15","author":"Quarto","year":"2012","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"10.1016\/j.ijcard.2018.09.091_bb0080","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jacc.2011.03.064","article-title":"Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis","volume":"58","author":"Dweck","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.09.091_bb0085","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1210\/jcem-73-4-727","article-title":"Variables controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects","volume":"73","author":"Clemmons","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ijcard.2018.09.091_bb0090","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1210\/endo.138.11.5472","article-title":"Insulin-like growth factor binding protein-2 binds to cell surface proteoglycans in the rat brain olfactory bulb","volume":"138","author":"Russo","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijcard.2018.09.091_bb0095","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/ijc.11015","article-title":"Novel stimulatory role for insulin-like growth factor binding protein-2 in prostate cancer cells","volume":"105","author":"Moore","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ijcard.2018.09.091_bb0100","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/glia.20719","article-title":"Matrix metalloproteinase-9 interplays with the IGFBP2-IGFII complex to promote cell growth and motility in astrocytomas","volume":"56","author":"Rorive","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.ijcard.2018.09.091_bb0105","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1055\/s-2006-924320","article-title":"Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome","volume":"114","author":"Heald","year":"2006","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.ijcard.2018.09.091_bb0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2009.11.007","article-title":"Antidiabetic effects of IGFBP2, a leptin-regulated gene","volume":"11","author":"Hedbacker","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.ijcard.2018.09.091_bb0115","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1055\/s-0032-1311534","article-title":"Prosthesis-patient mismatch after transcatheter aortic valve implantation using the Edwards SAPIEN prosthesis","volume":"61","author":"Van Linden","year":"2013","journal-title":"Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijcard.2018.09.091_bb0120","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jtcvs.2012.01.043","article-title":"Patient-prosthesis mismatch after transapical aortic valve implantation: incidence and impact on survival","volume":"145","author":"Kukucka","year":"2013","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijcard.2018.09.091_bb0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/CIRCIMAGING.111.967612","article-title":"Impact of prosthesis-patient mismatch on the regression of secondary mitral regurgitation after isolated aortic valve replacement with a bioprosthetic valve in patients with severe aortic stenosis","volume":"5","author":"Angeloni","year":"2012","journal-title":"Circ. Cardiovasc Imaging."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318345273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318345273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T16:46:47Z","timestamp":1547743607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527318345273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":25,"alternative-id":["S0167527318345273"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.09.091","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin like growth factor binding protein 2 (IGFBP-2) for risk prediction in patients with severe aortic stenosis undergoing Transcatheter Aortic Valve Implantation (TAVI)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.09.091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}